Prime Medicine, Inc. (PRME)
3.815
+0.14
(+3.95%)
USD |
NASDAQ |
Apr 17, 15:24
Prime Medicine Total Assets (Quarterly) : 616.64M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 488.95M |
| Lineage Cell Therapeutics, Inc. | 112.58M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 495.77M |
| Shareholders Equity (Quarterly) | 120.87M |
| Debt to Equity Ratio | 0.9633 |
| Current Ratio | 4.841 |
| Net Debt Paydown Yield | -2.40% |